Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<IPO>SIHUAN PHARM Spins Off XUANZHUBIO-B (02575.HK) for IPO Starting Tdy; Entry Fee $5,858.5
Recommend 49 Positive 102 Negative 43 |
||||
|
||||
|
SIHUAN PHARM (00460.HK) announced the details of the spin-off and IPO of XUANZHUBIO-B (02575.HK) in Hong Kong, planning to globally offer 67.3335 million H-shares, with 90% (approx. 60.6 million shares) for international placement and 10% (approx. 6.7335 million shares) for Hong Kong public offering. The offer price per share is $11.6, aiming to raise approx. $781 million. The entry for a board lot of 500 shares is about $5,858.5. The offering period starts today (6th), and will end this Friday (10th), with the listing anticipated on 15 October. CICC is its sole sponsor. The company's IPO introduced private equity fund Denov Ruilang Phase XV as its cornerstone investor, subscribing to shares worth approx. $76.6 million, equivalent to about 6.603 million shares at the offer price, representing approx. 9.81% of the offer shares. AASTOCKS Financial News Website: www.aastocks.com |
||||
Copied to Clipboard
 |
||||
